OIRA Conclusion of EO 12866 Regulatory Review
| RIN: 0584-AE94 View EO 12866 Meetings | Received Date: 09/08/2023 |
| Title: Special Supplemental Nutrition Program for Women, Infants, and Children (WIC): Implementation of the Access to Baby Formula Act of 2022 and Related Provisions | |
| Agency/Subagency: USDA / FNS | Stage: Final Rule |
| Concluded Action: Consistent with Change | Concluded Date: 11/14/2023 |
| Legal Deadline: None | Economically Significant: No |
| Publication Date: | Unfunded Mandates: No |
| Major: No | Related To Homeland Security: No |
| Regulatory Flexibility Analysis Required: No | Small Entities Affected: No |
| Federalism Implications: No | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
| International Impacts: No | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
| Pandemic Response: Yes | |
An official website of the United States government




